Mahzi, which is based on the Greek word for “Together”, aims to unite patient and family groups, academic researchers, other industry members, and our internal team of experts to develop therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders.

Our team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases.